Anito, Ashley O.
HRN: 27-10-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/25/2025
06/01/2025
IV
380 Mg
Q 8 Hours
Neonatal Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes